Restricted accessReview articleFirst published online 2026-3
Effect of E-Health-Assisted Lifestyle Interventions on Weight Loss in Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD,Formerly NAFLD): A Meta-Analysis
Lifestyle modification remains the cornerstone of managing metabolic dysfunction–associated steatotic liver disease (MASLD). Achieving a weight loss of 7% to 10% of total body weight is known to improve hepatic steatosis and reduce liver-related damage. However, sustained behavioral changes are often difficult to achieve without structured support. E-health technologies may offer scalable and accessible solutions to support weight management in this population.
Objective:
We aimed to evaluate the effect of e-health-assisted lifestyle interventions on weight loss in patients with MASLD.
Methods:
A systematic search was conducted in Ovid, ScienceDirect, Cochrane Library, Web of Science, CINAHL Ultimate, PubMed, Scopus, and MEDLINE. Randomized controlled trials (RCTs) reporting absolute weight change were included. Two reviewers independently assessed methodological quality using the Cochrane Risk of Bias-2 tool. Data were synthesized using a random-effects model in Comprehensive Meta-Analysis (v3).
Results:
Twelve RCTs involving 851 participants met the inclusion criteria. E-health-assisted interventions—delivered via text messaging, telephone/video calls, mobile apps, or multimodal strategies—targeted dietary and/or physical activity behaviors. The pooled analysis demonstrated a statistically significant moderate effect on weight loss (Hedges’ g = −0.45, 95% CI [−0.87, −0.03], P = .03). Moderator analysis indicated that intervention duration significantly influenced effectiveness, with greater effects observed in interventions lasting 3 to 6 months. No significant publication bias was detected.
Conclusion:
E-health-assisted lifestyle interventions are effective in promoting behavioral change and facilitating clinically meaningful weight loss in patients with MASLD. Healthcare providers, including nurses, can leverage these cost-effective, scalable tools to enhance chronic disease management, particularly when implemented over moderate durations.
RinellaMELazarusJVRatziuV, et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6):1966-1986. doi:10.1097/HEP.0000000000000520
2.
ByrneCDTargherG.NAFLD: a multisystem disease. J Hepatol. 2015;62(1 Suppl):47-64. doi:10.1016/j.jhep.2014.12.012
3.
ChalasaniNYounossiZLavineJECharltonMCusiKRinellaM.The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328-357. doi:10.1002/hep.29367
4.
LazarusJVMarkHEAllenAMArabJPCarrieriPNoureddinM.A global research priority agenda to advance public health responses to fatty liver disease. J Hepatol. 2023;79(3):618-634. doi:10.1016/j.jhep.2023.04.035
5.
European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. Hepatology. 2016;64(6):1388-1402. doi:10.1016/j.jhep.2015.11.004
6.
Nabizadeh HaghighiAShabaniR. Comparing effects of medication therapy and exercise training with diet on liver enzyme levels and liver sonography in patients with non-alcoholic fatty liver disease (NAFLD). J Fasa Univ Med Sci. 2016;5(4):488-500. doi:20.1001.1.22285105.2016.5.4.8.3
7.
GhodsbinFJavanmardifardSKavianMJJahanbinI.Effect of tele-nursing in the improving of the ultrasound findings in patients with nonalcoholic fatty liver diseases: a randomized clinical trial study. Invest Educ Enferm. 2018;36(3):e09. doi:10.17533/udea.iee.v36n3e09
8.
BuzzettiELindenABestLMMaddenAMRobertsDChaseTJ.Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis. Cochrane Database Syst Rev. 2021;6(6):CD13156. doi:10.1002/14651858.CD013156.pub2
9.
KonermanMAJonesJCHarrisonSA.Pharmacotherapy for NASH: current and emerging. Hepatology. 2018;68(2):362-375. doi:10.1016/j.jhep.2017.10.015
10.
Italian Association for the Study of the Liver (AISF). AISF position paper on nonalcoholic fatty liver disease (NAFLD): updates and future directions. Dig Liver Dis. 2017;49(5):471-483. doi:10.1016/j.dld.2017.01.147
11.
ChitturiSWongVWSChanWKWongGLHWongSKHSollanoJ.The Asia–Pacific working party on non-alcoholic fatty liver disease guidelines 2017-part 2: management and special groups. J Gastroenterol Hepatol. 2018;33(1):86-98. doi:10.1111/jgh.13856
12.
YounossiZMCoreyKELimJK.AGA clinical practice update on lifestyle modification using diet and exercise to achieve weight loss in the management of nonalcoholic fatty liver disease: expert review. Gastroenterology. 2021;160(3):912-918. doi:10.1053/j.gastro.2020.11.051
13.
Ivancovsky WajcmanDByrneCJDillonJF, et al. A narrative review of lifestyle management guidelines for metabolic dysfunction-associated steatotic liver disease. Hepatology. online ahead of print. 2024:01058. doi:10.1097/HEP.0000000000001058
14.
SaeedNNadeauBShannonCTincopaM.Evaluation of dietary approaches for the treatment of non-alcoholic fatty liver disease: a systematic review. Nutrients. 2019;11(12):3064. doi:10.3390/nu11123064
15.
Romero-GómezMZelber-SagiSTrenellM.Treatment of NAFLD with diet, physical activity and exercise. J Hepatol. 2017;67(4):829-846. doi:10.1016/j.jhep.2017.05.016
16.
Vilar-GomezEMartinez-PerezYCalzadilla-BertotLTorres-GonzalezAGra-OramasBGonzalez-FabianL.Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology. 2015;149(2):367-378. doi:10.1053/j.gastro.2015.04.005
17.
LeoniSTovoliFNapoliLSerioIFerriSBolondiL.Current guidelines for the management of non-alcoholic fatty liver disease: a systematic review with comparative analysis. World J Gastroenterol. 2018;24(30):3361-3373. doi:10.3748/wjg.v24.i30.3361
18.
KoutoukidisDAKoshiarisCHenryJA, et al. The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: a systematic review and meta-analysis. Metabolism. 2021;115:154455. doi:10.1016/j.metabol.2020.154455
19.
FaustAStineJG.Time to step it up: mobile health intervention for lifestyle modification in patients with nonalcoholic fatty liver disease. Dig Dis Sci. 2022;67(2):402-405. doi:10.1007/s10620-021-07018-x
20.
AveryLExleyCMcPhersonSTrenellMIAnsteQMHallsworthK.Lifestyle behavior change in patients with nonalcoholic fatty liver disease: a qualitative study of clinical practice. Clin Gastroenterol Hepatol. 2017;15(12):1968-1971. doi:10.1016/j.cgh.2017.06.011
21.
DongFZhangYHuangYWangYZhangGHuX.Long-term lifestyle interventions in middle-aged and elderly men with nonalcoholic fatty liver disease: a randomized controlled trial. Sci Rep. 2016;6:36783. doi:10.1038/srep36783
22.
JavanmardifardSGhodsbinFKavianiMJJahanbinI.The effect of telenursing on self-efficacy in patients with non-alcoholic fatty liver disease: a randomized controlled clinical trial. Gastroenterol Hepatol Bed Bench. 2017;10(4):263-271.
23.
DeneckeKGabarronEPetersenCMerolliM.Defining participatory health informatics—a scoping review. Inform Health Soc Care. 2021;46(3):234-243. doi:10.1080/17538157.2021.1883028
24.
KamraniFNikkhahSBorhaniFJalaliMShahsavariSNirumand-ZandiK.The effect of patient education and nurse-led telephone follow-up (telenursing) on adherence to treatment in patients with acute coronary syndrome. Iran J Car Nurs. 2015;4(3):16-24.
25.
ZahariaOPKupriyanovaYKarushevaYMarkgrafDFKantartzisKBirkenfeldAL.Improving insulin sensitivity, liver steatosis and fibrosis in type 2 diabetes by a food-based digital education-assisted lifestyle intervention program: a feasibility study. Eur J Nutr. 2021;60(7):3811-3818. doi:10.1007/s00394-021-02521-3
26.
Toro-RamosTMichaelidesAAntonM, et al. Mobile delivery of the diabetes prevention program in people with prediabetes: randomized controlled trial. JMIR mHealth uHealth. 2020;8(7):e17842. doi:10.2196/17842
27.
QinYWangXNamkoongK.A meta-analysis of the overall effect of mHealth physical activity interventions for weight loss and the moderating effect of behavioral change theories, techniques, and mobile technologies. Mob Media Commun. 2021;10(2):337-359. doi:10.1177/20501579211054929
28.
HigginsJPTThomasJChandlerJ, et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024). Cochrane, 2024. Accessed October 8, 2025. www.cochrane.org/handbook
29.
BorensteinMHedgesLVHigginsJPRothsteinHR.Introduction to Meta-Analysis. John Wiley & Sons; 2011.
30.
CohenJ.Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Erlbaum; 1988.
31.
EggerMSmithGDSchneiderMMinderC.Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-634. doi:10.1136/bmj.315.7109.629
32.
KoutoukidisDAJebbSATomlinsonJW, et al. Severe dietary energy restriction for compensated cirrhosis due to metabolic dysfunction-associated steatotic liver disease: a randomised controlled trial. J Cachexia Sarcopenia Muscle. 2025;16(3):e13783. doi:10.1002/jcsm.13783
33.
ChoEKimSKimS, et al. The effect of mobile lifestyle intervention combined with high-protein meal replacement on liver function in patients with metabolic dysfunction-associated steatotic liver disease: a pilot randomized controlled trial. Nutrients. 2024;16(14):2254. doi:10.3390/nu16142254
34.
KwonOYLeeMKLeeHWKimHLeeJSJangY.Mobile app-based lifestyle coaching intervention for patients with nonalcoholic fatty liver disease: randomized controlled trial. J Med Internet Res. 2024;26(1):e49839. doi:10.2196/49839
35.
LimSJohalJOngKWHanCYChanYHLeeYM.Lifestyle intervention enabled by mobile technology on weight loss in patients with nonalcoholic fatty liver disease: randomized controlled trial. JMIR mHealth uHealth. 2020;8(4):e14802. doi:10.2196/14802
36.
TincopaMAPatelNShahabAAsefaHLokAS.Implementation of a randomized mobile-technology lifestyle program in individuals with nonalcoholic fatty liver disease. Sci Rep. 2024;14(1):7452. doi:10.1038/s41598-024-57722-7
37.
StineJGRivasGHummerB, et al. Mobile health lifestyle intervention program leads to clinically significant loss of body weight in patients with NASH. Hepatol Commun. 2023;7(4):e0052. doi:10.1097/HC9.0000000000000052
38.
FreerCLGeorgeESTanSYAbbottGDalyRM.Delivery of a telehealth supported home exercise program with dietary advice to increase plant-based protein intake in people with non-alcoholic fatty liver disease: a 12-week randomised controlled feasibility trial. Br J Nutr. 2024;131(10):1709-1719. doi:10.1017/S0007114524000242
39.
StineJGSchreibmanIRFaustAJ, et al. NASHFit: a randomized controlled trial of an exercise training program to reduce clotting risk in patients with NASH. Hepatology. 2022;76(1):172-185. doi:10.1002/hep.32274
40.
AxleyPKodaliSKuoYFRaviSSeayTParikhNM.Text messaging approach improves weight loss in patients with nonalcoholic fatty liver disease: a randomized study. Liver Int. 2018;38(5):924-931. doi:10.1111/liv.13622
41.
KaewdechAAssawasuwannakitSChuruangsukCChamroonkulNSripongpunP.Effect of smartphone-assisted lifestyle intervention in MASLD patients: a randomized controlled trial. Sci Rep. 2024;14(1):13961. doi:10.1038/s41598-024-64988-4
42.
PolicarpoSMachadoMCortez-PintoH.Telemedicine as a tool for dietary intervention in NAFLD-HIV patients during the COVID-19 lockdown: a randomized controlled trial. Clin Nutr ESPEN. 2021;43:329-334. doi:10.1016/j.clnesp.2021.03.031
43.
LyzwinskiLN.A systematic review and meta-analysis of mobile devices and weight-loss with an intervention content analysis. J Pers Med. 2014;4(3):311-385. doi:10.3390/jpm4030311
44.
SiopisGCheyTAllman-FarinelliM.A systematic review and meta-analysis of interventions for weight management using text messaging. J Hum Nutr Diet. 2015;28(Suppl 2):1-15. doi:10.1111/jhn.12207
45.
KupilaSKJokiASuojanenLUPietiläinenKH.The effectiveness of eHealth interventions for weight loss and weight loss maintenance in adults with overweight or obesity: a systematic review of systematic reviews. Curr Obes Rep. 2023;12(3):371-394. doi:10.1007/s13679-023-00515-2
46.
LauYCheeDGHChowXPChengLJWongSN.Personalised eHealth interventions in adults with overweight and obesity: a systematic review and meta-analysis of randomised controlled trials. Prev Med. 2020;132:106001. doi:10.1016/j.ypmed.2020.106001
47.
KristAHTongSTAycockRALongoDR.Engaging patients in decision-making and behavior change to promote prevention. Inf Serv Use. 2017;37(2):105-122. doi:10.3233/ISU-170826
48.
CederbergMAlsénSAliL, et al. Effects of a person-centered eHealth intervention for patients on sick leave due to common mental disorders (PROMISE study): open randomized controlled trial. JMIR Ment Health. 2022;9(3):e30966. doi:10.2196/30966
49.
ZhuangMHassanIIW AhmadWMA, et al. Effectiveness of digital health interventions for chronic obstructive pulmonary disease: systematic review and meta-analysis. J Med Internet Res. 2025;27:e76323. doi10.2196/76323
50.
Canal-PérezANavas-OteroAOrtiz-RubioA, et al. E-Health interventions to improve health outcomes in patients with systemic lupus erythematosus: a systematic review. Healthcare. 2024;12(16);1603. doi:10.3390/healthcare12161603
51.
KimYIParkIJRoJS, et al. A randomized controlled trial of a digital lifestyle intervention involving postoperative patients with colorectal cancer. NPJ Digit Med. 2025;8(1):296. doi:10.1038/s41746-025-01716-w
52.
KwonOYChoiJYJangY.The effectiveness of ehealth interventions on lifestyle modification in patients with nonalcoholic fatty liver disease: systematic review and meta-analysis. J Med Internet Res. 2023;25:e37487. doi:10.2196/37487
53.
KumarRRaniMKumarV, et al. Effectiveness of mobile health intervention for non alcoholic fatty liver disease—a meta analysis of randomized controlled trials. Clin Res Hepatol Gastroenterol. 2024;48(8):102433. doi:10.1016/j.clinre.2024.102433
54.
SeifiNBahariHSoltaniS, et al. The effects of electronic-based lifestyle interventions on nonalcoholic fatty liver disease: a systematic review. Digit Health. 2023;9:20552076231187597. doi:10.1177/20552076231187597
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
